Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies

Prenatal Diagnosis

Volumn 24, Issue 2, 2004, Pages 125-129

  Maymon, Ron ^a,b   Shulman, Adrian ^b,c  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Down syndrome; Integrated test; IVF pregnancies; Screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CONTROLLED STUDY; CROWN RUMP LENGTH; DISEASE MARKER; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MATERNAL AGE; PRIORITY JOURNAL; REFERENCE VALUE; SCREENING TEST; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS;

ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ESTRIOL; FALSE POSITIVE REACTIONS; FEMALE; FERTILIZATION IN VITRO; HUMANS; INHIBINS; LONGITUDINAL STUDIES; MULTIPHASIC SCREENING; NECK; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 1542351161     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.809     Document Type: Article

References (31)

1. Bar-Hava I, Yitzhak M, Krissi H, et al. 2001. Triple-test screening in in vitro fertilization pregnancies. J Assist Reprod Genet 18: 226-229.
2. Benn P. 2003. Improved antenatal screening for Down's syndrome (commentary). Lancet 361: 794-795.
3. Bowes WA, Jr. 2000. Editorial. Obstet Gynecol Surv 55: 10-12.
4. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides KH. 2001. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 358: 1665-1667.
5. De Biasio P, Siccardi M, Volpe G, Famularo L, Santi F, Canini S. 1999. First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy - the combined test. Prenat Diagn 19: 360-363.
6. de Graaf IM, Pajkrt E, Bilardo CM, Leschot NJ, Cuckle HS, van Lith JMM. 1999. Early pregnancy screening for fetal aneuploidy with markers and nuchal translucency. Prenat Diagn 19: 458-462.
7. Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN, Jr. 1997. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 90: 98-101.
8. Gilbert RE, Augood C, Gupta R, et al. 2001. Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. BMJ 323: 423-425.
9. Heinonen S, Ryynanen M, Kirkinen P, Hippelainen M, Saarikoski S. 1996. Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down's syndrome screening. Fertil Steril 66: 398-403.
10. Howe D. 2002. Modeling doesn't predict reality accurately. BMJ 324: 111-112.
11. Hsu TY, Ou CY, Hsu JJ, Kung FT, Chang SY, Soong YK. 1999. Maternal serum screening for Down syndrome in pregnancies conceived by intra-uterine insemination. Prenat Diagn 19: 1012-1014.
12. Hui PW, Lam YH, Tang MH, Ng EH, Yeung WS, Ho PC. 2003. Amniotic fluid human chorionic gonadotrophin and alpha-fetoprotein levels in pregnancies conceived after assisted reproduction. Prenat Diagn 23: 484-487.
13. Lai TH, Chen SC, Tsai MS, Lee FK, Wei CF. 2003. First-trimester screening for Down syndrome in singleton pregnancies achieved by intrauterine insemination. J Assist Reprod Genet 20: 327-331.
14. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. 2001. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 16: 1501-1504.
15. Maymon R, Dreazen E, Rozinsky S, Bukovsky I, Weinraub Z, Herman A. 1999. Comparison of nuchal translucency measurement and second trimester serum screening following assisted reproduction. Prenat Diagn 19: 1007-1011.
16. Maymon R, Jauniaux E. 2002. Down syndrome screening in pregnancies after assisted reproductive techniques: an update. Reprod Biomed Online 4: 285-293.
17. Maymon R, Shulman A. 2001. Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies. Hum Reprod 16: 691-695.
18. Maymon R, Shulman A. 2002. Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally-conceived singletons. Hum Reprod 17: 1081-1085.
19. Niemimaa M, Heinonen S, Seppälä M, Hippelainen M, Martikainen H, Ryynanen M. 2001. First-trimester screening for Down's syndrome in in vitro fertilization pregnancies. Fertil Steril 76: 1282-1283.
20. Orlandi F, Rossi C, Allegra A, et al. 2002. First trimester screening with free β-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 22: 718-721.
21. Pandya PP, Snijders RJM, Johnson SJ, De Lourdes Brizot M, Nicolaides KH. 1995. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynecol 102: 957-962.
22. Räty R, Virtanen A, Koskinen P, et al. 2001. Maternal serum b-hCG levels in screening for Down syndrome are higher in singleton pregnancies achieved with ovulation induction and intrauterine insemination than in spontaneous singleton pregnancies. Fertil Steril 76: 1075-1077.
23. Räty R, Virtanen A, Koskinen P, et al. 2002. Serum free b-hCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down's syndrome. Hum Reprod 17: 481-484.
24. Ribbert LS, Kornman LH, De Wolf BT, et al. 1996. Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenat Diagn 16: 35-38.
25. Shohat M, Akstein E, Davidov B, et al. 1995. Amniocentesis rate and the detection of Down syndrome and other chromosomal anomalies in Israel. Prenat Diagn 15: 967-970.
26. Shulman A, Frenkel Y, Dor J, Levran D, Shiff E, Maschiach S. 1999. The best donor. Hum Reprod 14: 2493-2496.
27. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13: 231-237.
28. Wald N, Huttly W, Hackshaw A. 2003. Antenatal screening for Down's syndrome with the quadruple test. Lancet 361: 835-836.
29. Wald N, Watt HC, Hackshaw AK. 1999a. Integrated screening for Down syndrome based on tests performed during the first and second trimesters. N Engl J Med 341: 461-467.
30. Wald N, White N, Morris JK, Huttly WJ, Canick JA. 1999b. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening. Br J Obstet Gynecol 106: 1304-1306.
31. Wøjdeman KR, Larsen SO, Shalmi A, Sundberg K, Christiansen M, Tabor A. 2001. First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 21: 563-565.